## Abstract The clinical management of chronic hepatitis B infection has entered a new era with the introduction and widespread use of oral nucleoside analogues such as lamivudine and nucleotides such as adefovir dipivoxil. From this, new challenges have now emerged in terms of preventing antiviral
✦ LIBER ✦
Chronic Hepatitis B and C – current treatment and future therapeutic prospects
✍ Scribed by Christian Müller
- Publisher
- Springer Vienna
- Year
- 2006
- Tongue
- German
- Weight
- 75 KB
- Volume
- 156
- Category
- Article
- ISSN
- 0043-5341
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Treatment of chronic hepatitis B: curren
✍
Ruth Chin; Stephen Locarnini
📂
Article
📅
2003
🏛
John Wiley and Sons
🌐
English
⚖ 222 KB
Antiviral treatment of hepatitis C: pres
✍
Kazuhiko Koike
📂
Article
📅
2006
🏛
Springer
🌐
English
⚖ 283 KB
Treatment of Neuromuscular Channelopathi
✍
James C. Cleland; Robert C. Griggs
📂
Article
📅
2008
🏛
Springer-Verlag
🌐
English
⚖ 78 KB
Therapeutic neovascularization for coron
✍
Antonio D. Lassaletta; Louis M. Chu; Frank W. Sellke
📂
Article
📅
2011
🏛
Springer
🌐
English
⚖ 264 KB
Economic modeling of treatment in chroni
✍
Raymond S. Koff; Leonard B. Seeff
📂
Article
📅
1995
🏛
John Wiley and Sons
🌐
English
⚖ 411 KB
The past 3 decades have witnessed remarkable advances in knowledge about viral hepatitis. We have moved from the belief, before the early 1970s, that only two vaguely defined viruses existed (infectious and serum; A and B) to the identification by the mid-1990s of six cloned hepatitis agents (A thro
Benign hematopoietic progenitors in chro
✍
F. Cervantes; C. Rozman
📂
Article
📅
1994
🏛
Springer
🌐
English
⚖ 898 KB